Stage IVB Lung Cancer AJCC v8 Not Yet Recruiting Phase 1 / 2 Trials for Niraparib (DB11793)

IndicationStatusPhase
DBCOND0111251 (Stage IVB Lung Cancer AJCC v8)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03830918Niraparib and Temozolomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line ChemotherapyTreatment